- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02658539
Impact of Physiological, Lifestyle and Genetic Factors on Body Composition (BODYCON)
October 8, 2019 updated by: Julie Lovegrove, University of Reading
Research has shown that body composition is a key component of health and future disease risk.
Being overweight and obese is associated with a higher body fat composition, and a greater risk of developing type II diabetes and heart disease.
The location where fat is stored in the body is becoming increasingly recognised an important predictor of risk, with extra fat around the abdomen and waist (referred to as the android pattern of fat distribution or 'apple' shape) thought to increase your disease risk than storing fat around the thighs and buttocks (gynoid pattern of fat distribution or 'pear' shape).
As a result, there is significant interest in techniques to accurately monitor and detect changes in body composition, and also physiological and lifestyle factors which influence body fat, lean tissue mass and bone mineral density.
This cross sectional human study will look at how physiological, behavioural and genetic factors relate to total body composition in 1,196 healthy men and women aged between 18 and 70 years.
Interested applicants will be invited to attend for a single visit at the Hugh Sinclair Unit of Human Nutrition at the University of Reading.
This visit lasts around two hours and includes noninvasive measures of body composition (bio-electrical impedance and dual energy x-ray absorptiometry), arterial stiffness and fasting measures of metabolic health.
Diet and physical activity will then be monitored over a four day period using diet and activity diaries, and an activity monitor.
The findings from this study will contribute to the evidence base on how subject characteristics influence body composition and inform on the design of future human studies on body composition methodology.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
370
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Berkshire
-
Reading, Berkshire, United Kingdom, RG6 6AP
- Department of Food and Nutritional Sciences, University of Reading
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Men and women living in and around Reading, Berkshire, United Kingdom
Description
Inclusion Criteria:
- BMI 18.5-39.9 kg/m2
- Not having suffered a myocardial infarction/stroke in the past 12 months
- Not hyperlipidaemic (total cholesterol level < 7.8 mmol/l and triacylglycerol < 2.3 mmol/l).
- Not diabetic (diagnosed as fasting blood glucose > 7 mmol/l) or suffer from other endocrine disorders
- Not suffering from renal or bowel disease or have a history of cholestatic liver disease or pancreatitis
- Not diagnosed with cancer
- Not suffering from arthritis or fracture deformity of the spine or femur
- Not undergone bone related surgeries such as hip replacement or fusion(s)
- Not on drug treatment for hyperlipidaemia, hypertension, inflammation or hypercoagulation
- No history of alcohol abuse
- Not anaemic (Haemoglobin >115 g/l for women and 125 g/l for men)
Exclusion Criteria:
Due to the use of ionising radiation by the dual energy x-ray absorptiometry (DXA) scanner to assess total body composition and bone mineral density, the following exclusion criteria apply:
- Females who are breastfeeding, may be pregnant, or if of childbearing potential and are not using effective contraceptive precautions.
- Individuals with other radio-opaque implants (such as a knee or other joint replacement) or medical devices (such as a pacemaker).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total body composition
Time Frame: 1 year
|
Measured using dual-energy x-ray absorptiometry
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body composition
Time Frame: 1 year
|
Assessed using bio-electrical impedance
|
1 year
|
Fasting blood lipids
Time Frame: 1 year
|
Total cholesterol, triacylglycerol, high density lipoprotein cholesterol, low density lipoprotein cholesterol and non-esterified fatty acids
|
1 year
|
Markers of insulin resistance
Time Frame: 1 year
|
Glucose, insulin and indices of insulin resistance/sensitivity
|
1 year
|
Arterial stiffness
Time Frame: 1 year
|
Stiffness index and Reflection index measured using digital volume pulse and Mobil-O-Graph
|
1 year
|
Blood pressure
Time Frame: 1 year
|
Systolic and diastolic blood pressure
|
1 year
|
C-reactive protein
Time Frame: 1 year
|
Measured using a clinical chemistry analyser
|
1 year
|
Dietary intake
Time Frame: 1 year
|
Assessed using a 4-day weighed intake
|
1 year
|
Physical activity
Time Frame: 1 year
|
Assessed over 4 days using an accelerometer and activity diary
|
1 year
|
Anthropometric measurements
Time Frame: 1 year
|
Body mass index, waist circumference and hip circumference
|
1 year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Genotyping
Time Frame: 1 year
|
Single nucleotide polymorphisms in genes associated with body composition
|
1 year
|
Vitamin D status (25 hydroxy vitamin D)
Time Frame: 1 year
|
Assessed using HPLC or GC-MS
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2016
Primary Completion (Actual)
September 30, 2019
Study Completion (Actual)
September 30, 2019
Study Registration Dates
First Submitted
January 8, 2016
First Submitted That Met QC Criteria
January 14, 2016
First Posted (Estimate)
January 20, 2016
Study Record Updates
Last Update Posted (Actual)
October 10, 2019
Last Update Submitted That Met QC Criteria
October 8, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 13/55
- 14/SC/1095 (Other Identifier: NHS Research Ethics Committee)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Composition, Beneficial
-
Umeå UniversityUniversity of California; Semper AB; MRC Human Nutrition ResearchCompletedBody Composition, Beneficial | Dietary Modification | Infant DevelopmentSweden
-
University of MiamiHyperVibe Pty LtdWithdrawnBody Composition, Beneficial | Physical FitnessUnited States
-
Alexandre Guedes TorresRio de Janeiro State UniversityCompletedInflammation | Body Composition, Beneficial | Dietary ModificationBrazil
-
University of CopenhagenRigshospitalet, Denmark; Glostrup University Hospital, CopenhagenCompletedInsulin Resistance | Menopause | Body Composition, BeneficialDenmark
-
LudwLudwig Boltzmann Institute for COPD and Respiratory...Enrolling by invitationRespiration Disorders | Body Composition, BeneficialAustria
-
University of IcelandHarvard Medical School (HMS and HSDM); Massachusetts General Hospital; University...CompletedAdiposity | Body Composition, Beneficial | Growth Acceleration
-
Universidade Estadual de LondrinaCompletedOxidative Stress | Body Composition, Beneficial | Acute and Chronic Inflammation
-
University of North Carolina, Chapel HillCompletedOverweight | Obese | Body Composition, Beneficial | Satiety | Basal Metabolic RateUnited States
-
Rambam Health Care CampusCompletedSmoking Cessation | Muscle Weakness | Body Composition, BeneficialIsrael
-
University of California, IrvineWithdrawnBody Composition, BeneficialUnited States